Does LISOCABTAGENE MARALEUCEL Cause Disease progression? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Disease progression have been filed in association with LISOCABTAGENE MARALEUCEL (BREYANZI). This represents 2.7% of all adverse event reports for LISOCABTAGENE MARALEUCEL.
20
Reports of Disease progression with LISOCABTAGENE MARALEUCEL
2.7%
of all LISOCABTAGENE MARALEUCEL reports
14
Deaths
3
Hospitalizations
How Dangerous Is Disease progression From LISOCABTAGENE MARALEUCEL?
Of the 20 reports, 14 (70.0%) resulted in death, 3 (15.0%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LISOCABTAGENE MARALEUCEL. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does LISOCABTAGENE MARALEUCEL Cause?
Cytokine release syndrome (315)
Immune effector cell-associated neurotoxicity syndrome (129)
Neurotoxicity (101)
Pyrexia (47)
Fatigue (38)
Hypotension (38)
Febrile neutropenia (28)
Confusional state (27)
Death (25)
Lymphocyte adoptive therapy (25)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which LISOCABTAGENE MARALEUCEL Alternatives Have Lower Disease progression Risk?
LISOCABTAGENE MARALEUCEL vs LITHIUM
LISOCABTAGENE MARALEUCEL vs LIXISENATIDE
LISOCABTAGENE MARALEUCEL vs LOBAPLATIN
LISOCABTAGENE MARALEUCEL vs LOFEXIDINE
LISOCABTAGENE MARALEUCEL vs LOMITAPIDE